HTG Announces Availability of 96 Max Gene Expression Assay at American Association for Cancer Research Annual Meeting

DENVER--(BUSINESS WIRE)--HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) today announced the launch of the quantitative Nuclease protection assay (qNPA™) 96 Max gene expression assay at the American Association of Cancer Research (AACR) annual meeting. This new testing configuration enables the measurement of 46 genes in a 96 well Array Plate. The offering provides researchers with the ability to analyze a larger number of gene signatures for research and clinical validation work in academic and translational medicine.